{Photo Credit: Matt Iwanowicz/MSH}The MSH tuberculosis team delegation at a conference retreat.Photo Credit: Matt Iwanowicz/MSH

Management Sciences for Health’s (MSH’s) significant TB work was recognized as some of the best during this year’s 48th Annual World Conference on Lung Health that took place in Guadalajara, Mexico from October 11-14, 2017.

MSH staff from seven countries participated in a variety of symposia, workshops and presentations. MSH also produced three symposia, three workshops, 36 posters, 24 oral presentations, and six technical briefs and technical highlights to share our experience and expertise on a range of topics, including GeneXpert implementation scale-up; TB/HIV/diabetes integration model; QuanTB; Urban DOTS implementation, and more.

 {Photo credit: Jones Dizon/SIAPS.}Training participants try out the Pharmacovigilance Monitoring System (PViMS), a web-based application to help clinicians, regulatory bodies, and implementing partners monitor medicine safety specifically in resource-limited countries.Photo credit: Jones Dizon/SIAPS.

The Philippines has one of the highest TB burdens in the world—and 2.6% of its more than 286,000 new cases in 2015 were of multi-drug-resistant TB (MDR-TB). This threatens the progress the country has made in addressing the deadly disease over the past few decades and its goal to make the country TB-free by 2030. Further, MDR-TB cases will likely rise steadily in the Philippines and the world over the next two decades.

There’s a new medicine that can help. Through a partnership with Janssen Therapeutics of Johnson & Johnson that began in 2015, USAID introduced a program to distribute a new medicine called bedaquiline that helps patients with MDR-TB in low-income countries including the Philippines. The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program, which Management Sciences for Health (MSH) leads, has been helping to roll out bedaquiline in low- and middle-income countries.

But with any new treatment, active pharmacovigilance (PV) is needed to help ensure both patient safety and drug effectiveness. This means being able to monitor patients to identify and evaluate adverse events, such as unexpected or serious side effects, to better understand possible risks and improve treatment protocols.

{Photo Credit: Santita Ngo/MSH}Senior Technical Advisor for Supply Chain Management in Cote d'Ivoire, Ghislaine Djidjoho during an annual Leadership, Management, and Governance/National Malaria Control Program coordination meeting in November 2016.Photo Credit: Santita Ngo/MSH

In the global fight against malaria, National Malaria Control Programs (NMCPs) play a central role in leading national-level malaria control efforts. For NMCPs to fulfill this role, both the individual NMCP staff members and NMCPs as organizations must have the knowledge, skills, behaviors, and attitudes to successfully lead, coordinate, and manage malaria control efforts at all levels of the health system.

{Photo Credit: MSH}A nurse in Manika prepares to conduct a group education session on antenatal care, as part of the awareness campaign that helped Brigitte access the care she needed.Photo Credit: MSH

A campaign to promote antenatal care becomes a lifeline for a teenager in need.

We’re excited to bring you this month’s edition of Leading Voices, a series that features the incredible talent that makes up MSH.

We’re chatting with Degu Jerene, our project director in Ethiopia. Degu hails from Addis Ababa and has a passion for stopping the spread of infectious diseases like tuberculosis, malaria, and HIV. He’s responsible for leading the USAID-funded Challenge TB project in Ethiopia. Degu will be representing MSH this week at the Union World Conference on Lung Health in Guadalajara, Mexico.

What do you think makes MSH different?

Our expertise in health systems makes us unique. Others might be experts in childhood TB, for example, or research, or MDR-TB. But we have a comprehensive approach that looks at the health system as a whole and finds integrated solutions to very complex problems. At the same time, we are equally good or even better in disease specific areas.

What are you most proud of in your work?

Proving that our approach works. Gathering evidence and publishing it in peer-reviewed journals, which I’ve done dozens of times, is a contribution to the field I’m very proud of having made.

Finish this sentence: Health is _______.

A right, not a privilege.

{Photo Credit: Samy Rakotoniaina}Photo Credit: Samy Rakotoniaina

The entire population of Madagascar is at risk for malaria, and severe malaria is among the top five causes of death in the country, especially among young children, for whom the disease is a major killer of Malagasy children under five years of age. In this age group the national mortality rate is 7 percent, though this rate varies throughout Madagascar’s 22 regions; ranging from less than 1 percent in the central highlands to almost 11 percent in the coastal regions.

 {Photo credit: Alison Corbacio/MSH}From left: Ugochi Daniels, UNFPA; Chunmei Li, Johnson & Johnson; Antoine Ndiaye, MSH; Lara Zakaria, Syrian American Medical Society; Irene Koek, USAID; Loyce Pace, Global Health Council.Photo credit: Alison Corbacio/MSH

Health systems strengthening was front and center in discussions held in New York on the sidelines of the 72nd United Nations General Assembly. MSH hosted three events spotlighting how strong health systems are critical to resiliency and stability in fragile environments, at the core for global health security and essential for achieving universal health coverage. Here are some highlights from the week. See more on Twitter , and .

Pages

Printer Friendly Version
Subscribe to Management Sciences for Health RSS